Management protocol of venomous snakebite in India: a consensus statement
| Autor: | B. N. Mohapatra, D. P. Punde, S. Ragunanthatan, M. P. Jose, D. B. Mazumdar, H. S. Bawaskar, Jaideep Menon, S. Raut, P. D. Tanwar, Shivesh Tripathi, V V Pillay, Joseph K. Joseph, C. Rajendiran |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Disseminated intravascular coagulation
medicine.medical_specialty VIPeR biology business.industry Naja 030231 tropical medicine Toxicology medicine.disease biology.organism_classification complex mixtures 03 medical and health sciences Bungarus 0302 clinical medicine Echis carinatus Anesthesia Emergency medicine medicine Paralysis Indian cobra Common krait 030212 general & internal medicine medicine.symptom business |
| Zdroj: | Toxin Reviews. 35:147-151 |
| ISSN: | 1556-9551 1556-9543 |
| DOI: | 10.1080/15569543.2016.1185735 |
| Popis: | Venomous snakebite is a significant cause of mortality and morbidity in South East Asia. The WHO, in 2009 declared venomous snakebite as one of the “neglected diseases of the tropics”. It is estimated that there are over 300 000 snakebites in India alone leading to between 45 000 and 50 000 deaths annually. The majority of venomous bites could be attributed to the big four – Daboia russellii (Russell’s viper), Bungarus caerulus (common krait), Naja naja (Indian cobra) and the Echis carinatus (saw scaled viper). Hemostatic abnormalities are prima facie evidence of hemotoxic snakebite. This could range from a mild cutaneous bleed to catastrophic intra-cerebral bleeds. Hemotoxic snakebite could also lead to Acute Kidney Injury (AKI) and Disseminated Intravascular Coagulation (DIC). A descending paralysis starting as a ptosis, which could progress on to life threatening respiratory paralysis is what is seen in neurotoxic snakebites. Anti-snake venom is started at 10 vials (100 ml) and most bites requi... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|